Name | Number of supported studies | Average coverage | |
---|---|---|---|
neuron | 5 studies | 32% ± 19% | |
glutamatergic neuron | 5 studies | 28% ± 11% | |
retinal bipolar neuron | 3 studies | 31% ± 6% | |
interneuron | 3 studies | 33% ± 10% | |
rod bipolar cell | 3 studies | 23% ± 6% | |
GABAergic neuron | 3 studies | 32% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 31% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 8519.54 | 2424 / 2642 | 95% | 24.47 | 669 / 705 |
adrenal gland | 14% | 340.05 | 36 / 258 | 66% | 60.16 | 152 / 230 |
pancreas | 20% | 245.16 | 66 / 328 | 58% | 7.84 | 104 / 178 |
intestine | 3% | 35.05 | 33 / 966 | 20% | 1.47 | 108 / 527 |
stomach | 4% | 45.58 | 14 / 359 | 16% | 1.25 | 45 / 286 |
lung | 0% | 0 | 0 / 578 | 9% | 1.10 | 102 / 1155 |
bladder | 0% | 0 | 0 / 21 | 8% | 0.52 | 42 / 504 |
breast | 0% | 0 | 0 / 459 | 8% | 0.48 | 84 / 1118 |
esophagus | 0% | 0 | 0 / 1445 | 6% | 0.75 | 11 / 183 |
uterus | 0% | 0 | 0 / 170 | 5% | 0.16 | 25 / 459 |
eye | 0% | 0 | 0 / 0 | 5% | 0.48 | 4 / 80 |
ovary | 0% | 0 | 0 / 180 | 3% | 0.15 | 15 / 430 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.13 | 1 / 45 |
prostate | 0% | 0 | 0 / 245 | 2% | 0.02 | 8 / 502 |
liver | 0% | 0 | 0 / 226 | 1% | 0.03 | 5 / 406 |
skin | 0% | 2.66 | 3 / 1809 | 1% | 0.02 | 4 / 472 |
thymus | 0% | 4.41 | 2 / 653 | 0% | 0.01 | 1 / 605 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 2 / 901 |
adipose | 0% | 0.97 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.93 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0007283 | Biological process | spermatogenesis |
GO_0008380 | Biological process | RNA splicing |
GO_0030317 | Biological process | flagellated sperm motility |
GO_0048026 | Biological process | positive regulation of mRNA splicing, via spliceosome |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0030575 | Biological process | nuclear body organization |
GO_0016604 | Cellular component | nuclear body |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0036002 | Molecular function | pre-mRNA binding |
GO_0097322 | Molecular function | 7SK snRNA binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | CELF3 |
Protein name | CUGBP Elav-like family member 3 (CELF-3) (Bruno-like protein 1) (CAG repeat protein 4) (CUG-BP- and ETR-3-like factor 3) (ELAV-type RNA-binding protein 1) (ETR-1) (Expanded repeat domain protein CAG/CTG 4) (RNA-binding protein BRUNOL-1) (Trinucleotide repeat-containing gene 4 protein) CUG-BP and ETR-3 like factor 3 CUGBP Elav-like family member 3 |
Synonyms | BRUNOL1 CAGH4 TNRC4 ERDA4 |
Description | FUNCTION: RNA-binding protein involved in the regulation of pre-mRNA alternative splicing. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Activates the splicing of MAPT/Tau exon 10. Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. . |
Accessions | Q5SZQ8 ENST00000290583.9 [Q5SZQ8-1] Q8IZ97 ENST00000290585.8 [Q5SZQ8-4] H0Y623 ENST00000420342.1 |